Аннотация
Objetive: to determine the rate of mortality of cases with chronic kidney disease and its risk factors admitted to hospital with COVID-19 in Almaty City, Kazakhstan. Methods: patients with coronavirus infections who were hospitalized at a hospital in the Kazakhstani Almaty region from June 2020 until June 2022 are included in the retrospective analysis. The Unified National Electronic Healthcare System (UNEHS) provided the database extraction. Individuals were considered eligible if they had been admitted to the hospital with the primary diagnoses of U07.1 (COVID-19, detected virus) and U07.2. Conclusion: in Almaty, Kazakhstan, hospitalization outcomes for coronavirus patients with and without chronic kidney disease were assessed in this study. Analysis was done on the impact of comorbidities and sociodemographic characteristics on mortality. While there are many ways to prevent and manage chronic kidney disease (CKD), coexisting medical diseases, particularly viruses that cause pandemics, might complicate matters. Thus, to prevent unplanned infectious disease outbreaks, a thorough disease management plan must be established